Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock

被引:10
|
作者
Lee, Jae Ha [1 ]
Kim, Seong-Ho [2 ]
Jang, Ji Hoon [1 ]
Park, Jin Han [1 ]
Jo, Kyung Min [3 ]
No, Tae-Hoon [3 ]
Jang, Hang-Jea [1 ]
Lee, Hyun-Kyung [4 ]
机构
[1] Inje Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med,Haeundae Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea
[2] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Rheumatol,Coll Med, Busan, South Korea
[3] Inje Univ, Coll Med, Dept Internal Med, Div Infect Dis,Hundae Paik Hosp, Busan, South Korea
[4] Inje Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med,Busan Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea
关键词
biomarkers; procalcitonin; prognosis; sepsis; septic shock; CAMPAIGN INTERNATIONAL GUIDELINES; PROCALCITONIN; PRESEPSIN; BACTEREMIA; MANAGEMENT; ACCURACY;
D O I
10.1097/MD.0000000000031895
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is a life-threatening condition and remains a major cause of mortality. The aim of this study was to evaluate the role of biomarkers in the diagnosis of sepsis and septic shock in patients admitted to the emergency department (ED). Medical records of patients who underwent measurement of serum biomarkers including lactic acid, C-reactive protein, procalcitonin (PCT), and presepsin in the ED between May 2019 and May 2020 were retrospectively reviewed. Patients were subdivided into 3 groups; non-sepsis, sepsis, and septic shock according to the new definition using the sequential organ failure assessment score. The mean age was 69.3 years, and 55.8% of the study population was female. Of 249 subjects, 98 patients confined to sepsis group, and 35.7% of them were septic shock. In the multivariable analysis, a high level of PCT was an independent predictor of sepsis (odds ratio [OR], 1.028; 95% confidence interval [CI], 1.006-1.051; P = .011) along with a simplified acute physiology score III (SAPS III) (OR, 1.082; 95% CI, 1.062-1.103, P < .001). PCT was also an independent risk factor for septic shock (OR, 1.043; 95% CI, 1.016-1.071, P = .02). In the receiver operating characteristic curve analysis, the area under the curve of PCT to predict sepsis and septic shock were 0.691 (P < .001) and 0.734 (P < .001), respectively. The overall 30-days mortality rate was 8.8%, and the mortality rate was significantly higher in the sepsis group (sepsis vs non-sepsis, 15.3% vs 4.6%; P = .004). In the multivariate Cox analysis, a higher level of lactic acid (hazard ratio [HR], 1.328; 95% CI, 1.061-1.663, P = .013), predisposing chronic pulmonary diseases (HR, 7.035; 95% CI, 1.687-29.341, P = .007), and a high SAPSIII value (HR, 1.046; 95% CI, 1.015-1.078, P = .003) were independent risk factors for mortality in sepsis patients. PCT was a useful biomarker for predicting sepsis and septic shock in the ED. A higher level of lactic acid, predisposing chronic pulmonary diseases, and a high SAPS III score were associated with a greater mortality risk in patients with sepsis.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Sepsis and Septic Shock
    Maloney, Patrick J.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2013, 31 (03) : 583 - +
  • [42] Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
    Brunkhorst, FM
    Wegscheider, K
    Forycki, ZF
    Brunkhorst, R
    INTENSIVE CARE MEDICINE, 2000, 26 (Suppl 2) : S148 - S152
  • [43] Clinical review: Myocardial depression in sepsis and septic shock
    Olivier Court
    Aseem Kumar
    Joseph E Parrillo
    Anand Kumar
    Critical Care, 6
  • [44] Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
    F. M. Brunkhorst
    K. Wegscheider
    Z. F. Forycki
    R. Brunkhorst
    Intensive Care Medicine, 2000, 26 : S148 - S152
  • [45] Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
    FM Brunkhorst
    K Wegscheider
    ZF Forycki
    R Brunkhorst
    Critical Care, 3 (Suppl 1):
  • [46] Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression
    Beltran-Garcia, Jesus
    Osca-Verdegal, Rebeca
    Roma-Mateo, Carlos
    Carbonell, Nieves
    Ferreres, Jose
    Rodriguez, Maria
    Mulet, Sandra
    Garcia-Lopez, Eva
    Pallardo, Federico V.
    Garcia-Gimenez, Jose Luis
    EPIGENOMICS, 2020, 12 (07) : 617 - 646
  • [47] Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment
    Sandquist, Mary
    Wong, Hector R.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (10) : 1349 - 1356
  • [48] Genetic polymorphisms in sepsis and septic shock - Role in prognosis and potential for therapy
    Holmes, CL
    Russell, JA
    Walley, KR
    CHEST, 2003, 124 (03) : 1103 - 1115
  • [49] DEVELOPMENT AND VALIDATION OF A MODEL FOR PREDICTION OF SEPTIC SHOCK IN NEONATES WITH SEPSIS
    Liu, Chunmei
    Wang, Yanggan
    SHOCK, 2024, 62 (02): : 173 - 178
  • [50] PREDICTION OF SEPTIC SHOCK IN PATIENTS WITH INTRA-ABDOMINAL SEPSIS
    ROOS, H
    BULLER, HR
    TENCATE, JW
    CRITICAL CARE MEDICINE, 1981, 9 (03) : 212 - 212